Home >> Healthcare >> Food & Beverage >>

Singapore Pharmaceutical Market 2017 - Insights, Demand, Segmentation, Opportunities, Analysis and Forecast to 2025

Published: Sep-2017 | Format: PDF | Goldstein Research | Number of pages: 235 | Code: MRS - 169966

Singapore Pharmaceutical Market Outlook

Market Overview

Development of new medicines which can prevent and treat all incurable diseases is the main focus of global pharmaceutical industry. With impressive economic growth and demographic transformation, Asian pharmaceutical market is rising at a very faster rate. In terms of growth, Singapore is becoming a global center for pharmaceutical industry. Pharmaceutical manufacturing & production industry plays an important role in Singapore’s economy. In 2012, as per World Bank data, Singapore spends 4.7% of its GDP inthealthcare industry. Moreover, pharmaceutical industry contributes over 85% of total biomedical sciences manufacturing output of Singapore annually. As per World Health Organization (WHO), Singapore’s healthcare system holds sixth position worldwide.

Singapore’s pharmaceutical sector attracts many foreign companies for investments. For instance, more than 30 medtech companies have invested for research & development and in setting up pharmaceutical manufacturing plants in Singapore. Singapore’s multinational corporations and local startups are largest manufacturers and exporters of medical equipments across the world. Several medical products are exported from Singapore such as syringes, catheters, research instruments and scientific analytical equipments. Over 70% of world’s microarrays, 10% of global

Table of Contents
1. Executive Summary 
2. Research Methodology
3. Regional Opportunity Analysis on the basis of Competitors
4. Singapore Pharmaceutical Market (USD Billion) and Forecast Analysis, 2016-2024
5. Market Dynamics: Growth Drivers, Restraints and Opportunities
5.1. Risk Factors
5.2. Recent Trends and Developments
6. Singapore Pharmaceutical Market  Segmentation
6.1. Singapore Pharmaceutical Market By Products (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.1. Adoption Rate (%) by Components
6.1.2. Over-the-Counter (OCT) Drugs Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.3. Generic Drugs Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.4. Patented Drugs Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.5. Market Attractiveness by Products
6.1.6. BPS Analysis by Products
6.2. Singapore Pharmaceutical Market By Therapeutics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.1. Adoption Rate (%) by Therapeutics
6.2.2. Therapeutics for Cardiovascular Diseases (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.3. Therapeutics  for Diabetes (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.4. Therapeutics for Respiratory Diseases (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.5. Therapeutics for Infectious Diseases (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.6. Therapeutics for Oncology (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.7. Therapeutics for Gastrointestinal Problems (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.8. Therapeutics for Central Nervous System (CNS) Disorders (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.9. Therapeutics for Other Diseases 9Dermatology, Rheumatology) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.10. Market Attractiveness by Therapeutics
6.2.11. BPS Analysis by Therapeutics
7. Competitive Outlook
7.1. Market Share of Major Players (2016)
7.2. Company Profiles
7.2.1. Novartis International AG
7.2.1.1. Company Synopsis
7.2.1.2. Business Strategy
7.2.1.3. Product Portfolio
7.2.1.4. SWOT Analysis
7.2.2. GlaxoSmithKline (GSK)
7.2.3. Abbot Laboratories
7.2.4. Lonza
7.2.5. Merck Sharp & Dohme
7.2.6. Takeda
7.2.7. Roche Holding AG
7.2.8. Pfizer Inc.
7.2.9. Raffles Medical Group Ltd.
7.2.10. Wave Life Sciences
7.2.11. Sphaera Pharma
7.2.12. Special Access Pharma
7.2.13. Pharmaskin
7.2.14. NCI Health
7.2.15. Melbourne Drugs
8. Porter’s Five Force Model
9. Market Landscape: Competition and Beyond
10. Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem
11. Expert Analysis
12. Concluding Remarks







                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

Single User | $(USD)1275 View Pricing